Onconetix, Inc. Increase (Decrease) in Deferred Charges
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Deferred Charges of $225.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2026-03-13
- Onconetix, Inc. increase (decrease) in deferred charges for the quarter ending 2025-12-31 was $75.00K.
- Onconetix, Inc. increase (decrease) in deferred charges for fiscal 2025 was $225.00K.
- Onconetix, Inc. increase (decrease) in deferred charges for fiscal 2021 was $9.64K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $225.00K 10-K · filed 2026-03-13 | ||
| 2025-09-30 | $150.00K 10-Q · filed 2025-11-13 | |||
| 2021-12-31 | $9.64K 10-K · filed 2023-03-09 | |||
| 2021-06-30 | $30.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |